News tagged with food and drug administration
Related topics: drug , fda , centers for disease control and prevention , heart attack , patients
US approves new multiple sclerosis capsules
The U.S. Food and Drug Administration said Wednesday it approved a new drug from Biogen Idec to control multiple sclerosis in adults with hard-to-treat forms of the disease.
Medications
Mar 27, 2013 |
not rated yet |
0
Researchers help test cancer drug in clinical trial leading to FDA approval
The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).
Cancer
Mar 27, 2013 |
not rated yet |
0
A new wrinkle for botox: Research reveals how botulinum toxins affect neuron survival
(Medical Xpress)—Botulinum toxins are feared as a food poison and bioterror threat, and for good reason. It takes only minute amounts of these bacterial toxins to block signals from nerve cells that control ...
Medical research
Mar 27, 2013 |
3.5 / 5 (2) |
1
|
FDA aims to change the way it monitors safety of defibrillators
Defibrillators are supposed to save lives by shocking a patient's heart back into a normal rhythm, but they have malfunctioned in about 45,000 cases since 2005, according to the Food and Drug Administration. So on Friday, ...
Cardiology
Mar 26, 2013 |
not rated yet |
0
Battery-operated skin patch offers new option for migraine sufferers
(HealthDay)—The first skin patch approved to treat migraines offers patients an alternative to pills, nasal sprays and injections, the U.S. Food and Drug Administration says.
Diseases, Conditions, Syndromes
Mar 26, 2013 |
5 / 5 (1) |
0
|
Review article examines sublingual immunotherapy for treatment of allergic rhinitis and asthma
In an examination of a type of treatment for allergic rhinitis and asthma that is used in Europe but not approved by the U.S. Food and Drug Administration, researchers found moderate strength in the evidence from previous ...
Immunology
Mar 26, 2013 |
not rated yet |
0
|
Certified stroke centers more likely to give clot-busting drugs
Stroke patients are three times more likely to receive clot-busting medication if treated at a certified stroke center, according to a study in the Journal of the American Heart Association.
Cardiology
Mar 26, 2013 |
not rated yet |
0
Temporary tattoos may leave permanent damage
(HealthDay)—As thousands of college students head to sunny spots for spring break, getting temporary tattoos may seem like a fun thing to do. But the U.S. Food and Drug Administration warns that they can ...
Diseases, Conditions, Syndromes
Mar 26, 2013 |
5 / 5 (2) |
0
Inhaler approved for cystic fibrosis patients
(HealthDay)—The TOBI Podhaler (tobramycin inhalation powder) has been approved by the U.S. Food and Drug Administration to treat cystic fibrosis patients infected with Pseudomonas aeruginosa, a bacterium that can damage ...
Medications
Mar 25, 2013 |
not rated yet |
0
Court: Can drug companies pay to delay generics?
(AP)—Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue ...
Medications
Mar 24, 2013 |
5 / 5 (1) |
1
Judges side with FDA in rejecting stem cell device
(AP)—A federal appeals court is siding with the Food and Drug Administration in a case brought by medical device maker Cytori, ruling that the agency was correct to reject fast-track approval for two company devices used ...
Medications
Mar 22, 2013 |
3.7 / 5 (3) |
1
FDA proposes new rules for heart defibrillators
(AP)—The Food and Drug Administration will require makers of heart-zapping defibrillators to submit more data on their safety and effectiveness following years of recalls of the emergency devices.
Cardiology
Mar 22, 2013 |
not rated yet |
0
FDA: Georgia pharmacy recalling all sterile drugs
(AP)—The Food and Drug Administration says a Georgia compounding pharmacy that distributed a drug linked to eye infections is now recalling all of its injectable medicines following a federal inspection.
Medications
Mar 21, 2013 |
not rated yet |
0
Dotarem approved for nervous system MRIs
(HealthDay)—Dotarem (gadoterate meglumine) has been approved by the U.S. Food and Drug Administration as a contrast agent for use in MRIs of the brain, spine and other parts of the central nervous system.
Medications
Mar 21, 2013 |
5 / 5 (1) |
0
Researchers study use of dasatinib for patients with high-risk MDS
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia, ...
Cancer
Mar 21, 2013 |
not rated yet |
0
